A full-body PET scan shows areas of unusually high metabolic activity throughout your body, which can reveal cancer, heart disease, and brain disorders. It works by tracking how your cells consume sugar: cancer cells, inflamed tissue, and certain diseased areas burn through glucose far faster than normal cells, making them light up on the scan. This makes PET one of the most powerful tools for finding disease that other imaging misses.
How a PET Scan Produces Its Images
Before the scan, you receive an injection of a radioactive sugar molecule called FDG. It behaves almost identically to regular glucose. Your cells absorb it through the same channels and start processing it the same way. But FDG has a small chemical difference: it’s missing a component that cells need to fully break it down. So once it enters a cell, it gets stuck there.
Cancer cells are especially good at trapping FDG. They have more glucose transporters on their surface, they process sugar faster, and they lack the enzyme needed to push FDG back out. The result is that tumors accumulate far more of the radioactive tracer than surrounding healthy tissue. As the tracer decays, it releases tiny particles that collide with electrons in your tissue, producing pairs of photons that the PET camera detects. The scanner maps these signals into a 3D image where “hot spots” of high activity stand out clearly against quieter background tissue.
Cancer Detection and Staging
The most common reason for a full-body PET scan is cancer. It can reveal whether a known tumor has spread to lymph nodes, bones, or distant organs, and it can find cancers that don’t show up well on CT or MRI alone. For non-small cell lung cancer, PET is more sensitive than CT at detecting lymph node involvement: 71% sensitivity compared to 43% for CT. In one large study, PET changed the treatment plan for 13% of lung cancer patients by either finding previously unsuspected metastases (7%) or ruling out spread that CT had suggested (6%).
PET is particularly valuable for staging lymphomas, including diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma. National guidelines recommend it for initial staging and for checking whether treatment is working. It’s also a standard part of staging for esophageal cancer, breast cancer (stage IIB and above), multiple myeloma, and bone cancers like Ewing sarcoma and osteosarcoma. For bone metastases specifically, PET/CT is the most sensitive imaging method available.
Beyond staging, PET helps doctors choose the best biopsy site by identifying the most metabolically active part of a tumor, which is most likely to yield a definitive diagnosis.
What PET Reveals in the Brain
When focused on the brain, PET can visualize glucose metabolism patterns, dopamine receptor activity, and the buildup of abnormal proteins linked to dementia. In Alzheimer’s disease, the scan shows decreased glucose consumption in specific brain regions well before symptoms become severe. Specialized PET tracers can also detect amyloid plaques, the protein deposits characteristic of Alzheimer’s, up to 10 years before clinical symptoms appear. Three FDA-approved tracers exist specifically for this purpose.
Different types of dementia produce distinct patterns on PET. Alzheimer’s typically shows reduced activity in the back and sides of the brain, while frontotemporal dementia shows reduced activity in the front and temporal regions. This distinction matters because these conditions can look similar on standard brain scans but require different management approaches. PET also helps locate seizure sources in epilepsy patients, identifying areas of abnormal metabolism that may be candidates for surgical treatment.
Heart Muscle Viability
In cardiology, PET scans answer a critical question: is damaged heart muscle still alive? After a heart attack or in patients with chronic coronary artery disease, some heart muscle may appear to stop working but isn’t actually dead. This “hibernating” tissue has switched from burning fatty acids to burning glucose for survival, and FDG PET can detect that switch.
The scan reveals three distinct patterns. Hibernating muscle shows reduced blood flow but preserved FDG uptake, meaning it’s alive and could recover if blood flow is restored. A complete scar shows no blood flow and no FDG uptake, meaning the tissue is gone. A partial scar falls somewhere in between. This information directly shapes whether a patient benefits from bypass surgery or stenting, since restoring blood flow only helps if there’s living tissue to save.
What Hot Spots Don’t Always Mean
Not every bright area on a PET scan is cancer. Any tissue with high metabolic activity will absorb more FDG, and that includes infections, inflammation, healing surgical sites, and certain benign conditions. Sarcoidosis, active scar tissue formation (fibrosis), granulomas, and even some benign blood vessel tumors can all produce false-positive results. Your brain, liver, and kidneys naturally show high uptake because they’re metabolically active organs.
This is why PET results are always interpreted alongside other imaging, your medical history, and sometimes biopsy results. A common approach when a spot shows uptake no greater than surrounding tissue and the overall risk of cancer is low is to simply monitor it with follow-up imaging rather than pursue immediate biopsy. The intensity of FDG uptake is measured using a standardized uptake value (SUV), a number that reflects how much tracer accumulated relative to what you’d expect if it spread evenly throughout your body. While higher SUVs raise more concern, there’s no single cutoff that reliably separates cancer from non-cancer. The visual pattern and clinical context matter just as much as the number.
Preparing for the Scan
Preparation centers on keeping your blood sugar stable and low. You’ll need to fast for at least four hours beforehand, avoiding all food, gum, mints, and nutritional supplement drinks. Only water is allowed. The reason is straightforward: if your blood sugar is high, your normal cells are already flooded with glucose and compete with the tracer for absorption, which washes out the contrast between healthy and diseased tissue. Most facilities want your blood sugar between 50 and 200 mg/dL, ideally below 150. A reading above 200 may mean your scan gets rescheduled.
If you take insulin, it should not be administered within four hours of your appointment. You’ll also be asked to drink one or two glasses of water in the two hours before the scan to stay hydrated and help the tracer distribute properly.
What Happens During the Scan
After the tracer injection, you’ll wait quietly for about 60 minutes. Guidelines specify an acceptable window of 55 to 75 minutes. During this uptake period, you’ll be asked to sit or lie still and avoid talking, chewing, or moving around, since muscle activity absorbs FDG and can create misleading signals. The actual scan itself typically takes 20 to 30 minutes, during which you lie on a table that moves slowly through the scanner.
Most modern PET scanners are combined with a CT scanner in the same machine (PET/CT), so you get both a metabolic map and a detailed anatomical image in a single session. The CT portion helps pinpoint exactly where hot spots are located within your body’s structures.
Radiation Exposure
A full-body PET/CT delivers a total radiation dose in the range of about 10 to 17 millisieverts (mSv), depending on your sex and the specific CT protocol used. Roughly half comes from the FDG tracer itself (around 7 to 9 mSv) and half from the CT component (about 7 to 8 mSv). For comparison, a standard chest CT is around 7 mSv, and the average person absorbs about 3 mSv per year from natural background radiation. The tracer’s radioactive component has a half-life of about 110 minutes, so it loses most of its activity within a few hours and clears from your body through your urine.